.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Queensland Health
Cantor Fitzgerald
US Department of Justice
Farmers Insurance
US Army
Moodys
Deloitte
Teva

Pharmaceutical companies with the most 'New Chemical Entity' drugs

Five years of exclusivity is provided for drugs which do not contain active molecules that have appeared in previously-approved drugs.

This is one of the longest exclusivity terms provided by the FDA. Only orphan drugs receive a longer term of exclusivity, although the five years granted under the Generating Antibiotic Incentives Now (GAIN) Act may be added in addition to other exclusivities, giving it an effetively longer span.

This chart shows the companies which have received the most new chemical entity exclusivities in the past five years.

The companies with the most orphan drug approvals are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot